Amsterdam Molecular Therapeutics
Latest round
- Series A
Last raised
- Oct 2006
Total raised
- $22M
Investors
- 4
About Amsterdam Molecular Therapeutics
Amsterdam Molecular Therapeutics BV (AMT) is a gene therapy company founded by scientists and funds of the Academic Medical Center.
Who invested in Amsterdam Molecular Therapeutics
4 investors across 1 round
See all investors in Amsterdam Molecular Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 4, 2006
Amount
$22M
Investors
Questions about Amsterdam Molecular Therapeutics
Who invested in Amsterdam Molecular Therapeutics?
Amsterdam Molecular Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amsterdam Molecular Therapeutics raised?
Amsterdam Molecular Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Amsterdam Molecular Therapeutics last raise money?
Amsterdam Molecular Therapeutics's most recent round on record is a Series A, in Oct 2006.
What does Amsterdam Molecular Therapeutics do?
Amsterdam Molecular Therapeutics BV (AMT) is a gene therapy company founded by scientists and funds of the Academic Medical Center.
Where is Amsterdam Molecular Therapeutics headquartered?
Amsterdam Molecular Therapeutics is headquartered in Amsterdam, Netherlands.
Which VCs invest in companies like Amsterdam Molecular Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Amsterdam Molecular Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Amsterdam Molecular Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.